Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon

References

• Akhgari, A., et al., 2005. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. International journal of pharmaceutics, 305, 22–30.
   PubMed Web of Science ®Google Scholar
• Amidon, S., Brown, J.E., and Dave, V.S., 2015. Colon-targeted oral drug delivery systems: design trends and approaches. Aaps pharmscitech, 16, 731–741.
   PubMed Web of Science ®Google Scholar
• Bolcskei, E., et al., 2012. Optimization of preparation of matrix pellets containing Eudragit® NE 30D. Chemical engineering research and design, 90, 651–657.
   Web of Science ®Google Scholar
• Cheng, G., et al., 2004. Time-and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid. World journal of gastroenterology, 10, 1769.
   PubMed Web of Science ®Google Scholar
• Chourasia, M., and Jain, S., 2003. Pharmaceutical approaches to colon targeted drug delivery systems. Journal of pharmacy pharmaceutical sciences: a publication of the Canadian society for pharmaceutical sciences [Societe Danadienne des sciences pharmaceutiques], 6, 33–66.
   Google Scholar
• Chourasia, M., and Jain, S., 2004. Design and development of multiparticulate system for targeted drug delivery to colon. Drug delivery, 11, 201–207.
   PubMed Web of Science ®Google Scholar
• Dey, N., Majumdar, S., and Rao, M., 2008. Multiparticulate drug delivery systems for controlled release. Tropical journal of pharmaceutical research, 7, 1067–1075.
   Web of Science ®Google Scholar
• Eriksson, M., et al., 1997. Comparison between and evaluation of some methods for the assessment of the sphericity of pellets. International journal of pharmaceutics, 148, 149–154.
   Web of Science ®Google Scholar
• Evans, D., et al., 1988. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 29, 1035–1041.
   PubMed Web of Science ®Google Scholar
• Fallingborg, J., 1999. Intraluminal pH of the human gastrointestinal tract. Danish medical bulletin, 46, 183–196.
   PubMed Web of Science ®Google Scholar
• Farkouh, A., et al., 2010. A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes. Anticancer research, 30, 5207–5211.
   PubMed Web of Science ®Google Scholar
• Gandhi, R., Kaul, C.L., and Panchagnula, R., 1999. Extrusion and spheronization in the development of oral controlled-release dosage forms. Pharmaceutical science & technology today, 2, 160–170.
   Google Scholar
• Gazzaniga, A., et al., 1994. Oral delayed-release system for colonic specific delivery. International journal of pharmaceutics, 108, 77–83.
   Web of Science ®Google Scholar
• Ghebre-Sellassie, I., 1989. Pellets: a general overview. Pharmaceutical pelletization technology, 37, 1–15.
   Google Scholar
• Goskonda, S.R., and Upadrashta, S.M., 1993. Avicel RC-591/chitosan beads by extrusion-spheronization technology. Drug development and industrial pharmacy, 19, 915–927.
   Web of Science ®Google Scholar
• Guichard, S.M., Mayer, I., and Jodrell, D.I., 2005. Simultaneous determination of capecitabine and its metabolites by HPLC and mass spectrometry for preclinical and clinical studies. Journal of chromatography B, 826, 232–237.
   PubMed Web of Science ®Google Scholar
• Häring, A., et al., 2008. Differences in characteristics of pellets prepared by different pelletization methods. Drug development and industrial pharmacy, 34, 289–296.
   PubMed Web of Science ®Google Scholar
• Hasznos, L., Langer, I., and Gyarmathy, M., 1992. Some factors influencing pellet characteristics made by an extrusion/spheronisation process Part I.: effects on size characteristics and moisture content decrease of pellets. Drug development and industrial pharmacy, 18, 409–437.
   Web of Science ®Google Scholar
• Hileman, G.A., et al., 1993. Response surface optimization of high dose pellets by extrusion and spheronization. International journal of pharmaceutics, 100, 71–79.
   Web of Science ®Google Scholar
• Jain, A., Gupta, Y., and Jain, S.K., 2007. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. Journal of pharmacy pharmaceutical sciences: a publication of the Canadian society for pharmaceutical sciences [Societe Canadienne des sciences pharmaceutiques], 10, 86–128.
   Google Scholar
• Khan, M.Z.I., Prebeg, Z., and Kurjakovic, N., 1999. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers: I. Manipulation of drug release using Eudragit® L100-55 and Eudragit® S100 combinations. Journal of controlled release, 58, 215–222.
   PubMed Web of Science ®Google Scholar
• Koukourakis, G.V., et al., 2010. Capecitabine for locally advanced and metastatic colorectal cancer: a review. World journal of gastrointestinal oncology, 2, 311–321.
   PubMed Web of Science ®Google Scholar
• Kulthe, S., et al., 2013. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach. Drug development and industrial pharmacy, 39, 138–145.
   PubMed Web of Science ®Google Scholar
• Lokich, J., 2004. Capecitabine: fixed daily dose and continuous (noncyclic) dosing schedule. Cancer investigation, 22, 713–717.
   PubMed Web of Science ®Google Scholar
• Maulvi, F.A., et al., 2014. Optimization of aceclofenac solid dispersion using Box-Behnken design: in-vitro and in-vivo evaluation. Current drug delivery, 11, 380–391.
   PubMed Web of Science ®Google Scholar
• Maulvi, F.A., et al., 2015. Application of Box-Behnken design in optimization of ibuprofen ternary solid dispersion. Journal of pharmacy and applied sciences, 2, 11.
   Google Scholar
• Maulvi, F.A., et al., 2017. Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: in vitro and in vivo evaluation. Acta biomaterialia, 53, 211–221.
   PubMed Web of Science ®Google Scholar
• Mehta, R., et al., 2013. Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system. Journal of advanced pharmaceutical technology & research, 4, 31–41.
   PubMedGoogle Scholar
• Muley, S., Nandgude, T., and Poddar, S., 2016. Extrusion–spheronization a promising pelletization technique: In-depth review. Asian journal of pharmaceutical sciences, 11, 684–699.
   Web of Science ®Google Scholar
• Paharia, A., et al., 2007. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS pharmscitech, 8, E87–E93.
   Web of Science ®Google Scholar
• Pandey, S., et al., 2014. Novel time and site specific “tablets in capsule” system for nocturnal asthma treatment. Journal of pharmaceutical investigation, 44, 381–390.
   Google Scholar
• Rahman, M.A., et al., 2009. Recent advances in pelletization technique for oral drug delivery: a review. Current drug delivery, 6, 122–129.
   PubMedGoogle Scholar
• Reigner, B., Blesch, K., and Weidekamm, E., 2001. Clinical pharmacokinetics of capecitabine. Clinical pharmacokinetics, 40, 85–104.
   PubMed Web of Science ®Google Scholar
• Rodri´guez, M., Vila-Jato, J.L., and Torres, D., 1998. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. Journal of controlled release, 55, 67–77.
   PubMed Web of Science ®Google Scholar
• Roy, P., and Shahiwala, A., 2009. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. Journal of controlled release, 134, 74–80.
   PubMed Web of Science ®Google Scholar
• Sadeghi, F., et al., 2000. Comparative study of drug release from pellets coated with HPMC or Surelease. Drug development and industrial pharmacy, 26, 651–660.
   PubMed Web of Science ®Google Scholar
• Siegel, R.L., et al., 2017. Colorectal cancer statistics, 2017. CA: A cancer journal for clinicians, 67, 7–30.
   PubMed Web of Science ®Google Scholar
• Srivastava, S., and Mishra, G., 2010. Fluid bed technology: overview and parameters for process selection. International journal of pharmaceutical sciences and drug research, 2, 236–246.
   Google Scholar
• Timmers, L., et al., 2012. The use of capecitabine in daily practice: a study on adherence and patients’ experiences. Patient prefer adherence, 6, 741–748.
   PubMed Web of Science ®Google Scholar
• Vertomrnen, J., and Kinget, R., 1997. The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor. Drug development and industrial pharmacy, 23, 39–46.
   Web of Science ®Google Scholar
• Vervaet, C., Baert, L., and Remon, J.P., 1995. Extrusion-spheronisation: a literature review. International journal of pharmaceutics, 116, 131–146.
   Web of Science ®Google Scholar
• Wang, L., et al., 2011. Effects and patient compliance of sustained‐release versus immediate‐release glipizides in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis. Journal of evidence-based medicine, 4, 232–241.
   PubMedGoogle Scholar
• Yang, L., Chu, J.S., and Fix, J.A., 2002. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. International journal of pharmaceutics, 235, 1–15.
   PubMed Web of Science ®Google Scholar
• Yu, Y.-Y., 2010. Perspectives on the treatment of colorectal carcinoma. World journal of gastrointestinal oncology, 2, 229–234.
   PubMed Web of Science ®Google Scholar